
The UK competition regulator says AkzoNobel's planned merger with Axalta could reduce competition in UK markets.
The UK Competition and Markets Authority (CMA) has raised concerns over AkzoNobel's planned merger with Axalta. Its first-stage review found the deal could reduce competition in one or more UK markets. The CMA announced the phase 1 decision on 11 November 2026.
The case now heads for an in-depth phase 2 investigation. The parties can avoid that by offering acceptable undertakings to meet the concerns. The CMA published a summary of its decision the same day. It opened the case on 16 April 2026 with an invitation to comment. The formal inquiry began on 16 September. The CMA lists the case under chemicals.
The UK decision follows approval in Brussels. The European Commission cleared the merger earlier this month, subject to conditions. The same day, the CMA reached the same finding on a second deal. That deal is McCormick's planned purchase of most of Unilever's foods business.
Published under the editorial responsibility of Kelly Moon, Editor-in-Chief




